Imperial College London

ProfessorSteveMarston

Faculty of MedicineNational Heart & Lung Institute

(Non-Clinical) Professor in Cardiovascular Biochemistry
 
 
 
//

Contact

 

+44 (0)20 7594 2732s.marston Website

 
 
//

Location

 

433ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Marston:2017:10.1007/s12551-017-0264-8,
author = {Marston, S},
doi = {10.1007/s12551-017-0264-8},
journal = {Biophysical Reviews},
pages = {239--243},
title = {Obscurin variants and inherited cardiomyopathies},
url = {http://dx.doi.org/10.1007/s12551-017-0264-8},
volume = {9},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - The inherited cardiomyopathies, hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) and left ventricular non-compaction (LVNC), have been frequently associated with mutations in sarcomeric proteins. In recent years, advances in DNA sequencing technology has allowed the study of the giant proteins of the sarcomere, such as titin and nebulin. Obscurin has been somewhat neglected in these studies, largely because its functional role is far from clear, although there was an isolated report in 2007 of obscurin mutations associated with HCM. Recently, whole exome sequencing methodology (WES) has been used to address mutations in OBSCN, the gene for obscurin, and OBSCN variants were found to be relatively common in inherited cardiomyopathies. In different studies, 5 OBSCN unique variants have been found in a group of 30 end-stage failing hearts, 6 OBSCN unique variants in 74 HCM cases and 3 OBSCN unique variants in 10 LVNC patients. As yet, the number of known potentially disease-causing OBSCN variants is quite small. The reason for this is that mutations in the OBSCN gene have not been recognised as potentially disease-causing until recently, and were not included in large-scale genetic surveys. OBSCN mutations may be causative of HCM, DCM and LVNC and other cardiomyopathies, or they may work in concert with other variants in the same or other genes to initiate the pathology. Currently, the function of obscurin is not well understood, but we anticipate that many more OBSCN variants linked to cardiomyopathy will be found when the large cohorts of patient sequences available are tested. It is to be hoped that the establishment of the importance of obscurin in pathology will stimulate a thorough investigation of obscurin function.
AU - Marston,S
DO - 10.1007/s12551-017-0264-8
EP - 243
PY - 2017///
SN - 1867-2450
SP - 239
TI - Obscurin variants and inherited cardiomyopathies
T2 - Biophysical Reviews
UR - http://dx.doi.org/10.1007/s12551-017-0264-8
UR - https://www.ncbi.nlm.nih.gov/pubmed/28510120
UR - http://hdl.handle.net/10044/1/49509
VL - 9
ER -